Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 327
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03601819 | Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders | ||
| NCT00005598 | Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome | ||
| NCT05867667 | Cardiac Rehabilitation to Improve Breast Cancer Outcomes | ||
| NCT00580983 | Optimized Intensity Modulated Irradiation for Head and Neck Cancer | ||
| NCT00176748 | Treatment for Patients With Metastatic Thyroid Cancer | ||
| NCT00959998 | Acupressure for Post-Treatment Cancer Fatigue | ||
| NCT00639717 | Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant | ||
| NCT03556904 | FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE) | ||
| NCT00982995 | Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients | ||
| NCT03235869 | Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma | ||
| NCT00116961 | Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma | ||
| NCT01661062 | A Study Using Cone Beam CT for Head and Neck Cancer | ||
| NCT02097732 | Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery | ||
| NCT00637390 | A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. | ||
| NCT00141765 | Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers | ||
| NCT05169957 | Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) | ||
| NCT00645593 | Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer | ||
| NCT02338115 | Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients | ||
| NCT04431635 | Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma | ||
| NCT00148135 | Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site | ||
| NCT02485470 | Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy | ||
| NCT04272645 | Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer | ||
| NCT01661088 | A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients | ||
| NCT01912612 | Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain | ||
| NCT02973711 | A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML | ||
| NCT04480541 | A Pilot Study of Roadmap 2.0 in Oncology Caregivers and Patients | ||
| NCT02729194 | Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma | ||
| NCT01975597 | Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer | ||
| NCT03240016 | Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer | ||
| NCT02460835 | A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma | ||
| NCT03639935 | Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy | ||
| NCT05988918 | Multicenter Trial of ESK981 in Patients With Select Solid Tumors | ||
| NCT04845035 | Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia | ||
| NCT00967824 | Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer | ||
| NCT03618017 | The ConnectedCancerCare Pilot Study (CCC) | ||
| NCT02677948 | Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) | ||
| NCT02400190 | The IDEA Study (Individualized Decisions for Endocrine Therapy Alone) | ||
| NCT05911269 | Feasibility of Virtual, Tailored, Music-Based Relaxation for Anxiety in Adolescent and Young Adult Cancer Survivors | ||
| NCT03781986 | APG-115 in Salivary Gland Cancer Trial | ||
| NCT04748042 | Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON) | ||
| NCT02145403 | Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies | ||
| NCT01073436 | Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha | ||
| NCT03287063 | Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma | ||
| NCT03559049 | Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer | ||
| NCT02946008 | Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer | ||
| NCT02138578 | Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma | ||
| NCT00615589 | Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen | ||
| NCT06915168 | CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer | ||
| NCT00858585 | Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study | ||
| NCT02331368 | Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma |
